piperidine has been researched along with isoxazoles in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fotsch, C; St Jean, DJ | 1 |
Corniquet, XG; Marsh, GP; McCarthy, C; Parsons, PJ | 1 |
Alper, PB; Bao, D; Bursulaya, B; Chianelli, D; Groessl, T; Joseph, SB; Kim, Y; Laffitte, B; Liu, B; McNamara, P; Molteni, V; Mutnick, D; Phimister, A; Rucker, PV; Schmeits, J; Seidel, HM; Tully, DC; Vidal, A; Williams, J; Wu, X; Zoll, J | 1 |
Aparna, P; Bhavani, AKD; Gautier, F; Grée, R; Juin, P; Le Guevel, R; Levoin, N; Mosset, P; Murthy, AVR; Narendar, V; Reddy, CR; Roul, J; Sampath Kumar, N; Solhi, H | 1 |
1 review(s) available for piperidine and isoxazoles
Article | Year |
---|---|
Mitigating heterocycle metabolism in drug discovery.
Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats | 2012 |
3 other study(ies) available for piperidine and isoxazoles
Article | Year |
---|---|
An efficient synthesis of nitroalkenes by alkene cross metathesis: facile access to small ring systems.
Topics: Alkenes; Cyclization; Cyclopentanes; Indicators and Reagents; Isoxazoles; Nitro Compounds; Piperidines | 2007 |
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).
Topics: Administration, Oral; Animals; Benzothiazoles; Biological Availability; Cholestasis; Dogs; Drug Evaluation, Preclinical; Fibroblast Growth Factors; Gene Expression Regulation; Humans; Isoxazoles; Male; Microsomes, Liver; Non-alcoholic Fatty Liver Disease; Piperidines; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Triglycerides | 2017 |
Synthesis and biological studies of new piperidino-1,2,3-triazole hybrids with 3-aryl isoxazole side chains.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isoxazoles; Models, Molecular; Molecular Structure; Piperidines; Structure-Activity Relationship; Triazoles | 2021 |